AEVLI journal
The latest AEVLI evidence profiles, comparisons and practical guides in one place.
Safe self-injection: preparation, technique and aftercare
Three clear guides for prescribed self-injection after hands-on training, including preparation, subcutaneous technique boundaries and sharps disposal.
Read article →Evidence profile · Approved peptide medicineTesamorelin: evidence, mechanism and FDA status
What the GHRH analogue is approved for, what randomized human studies show and where the evidence should not be extrapolated.
Read article →Evidence profile · Investigational medicineRetatrutide: human evidence and investigational status
A clear look at the triple GIP, GLP-1 and glucagon receptor agonist, its clinical-development evidence and current regulatory status.
Read article →Evidence profile · Research peptideBPC-157: what does the human evidence actually show?
Separate the extensive preclinical discussion from the much thinner human evidence and current regulatory context.
Read article →Comparison guide · ComparisonBPC-157 vs TB-500
Compare what is actually known about these two popular research compounds without treating animal data as proven human benefit.
Read article →Comparison guide · GLP-1 & metabolicSemaglutide vs Tirzepatide vs Retatrutide
Compare receptor targets, approval status and the maturity of the human evidence across three widely discussed medicines or candidates.
Read article →Practical guide · Evidence guideHow to read a peptide certificate of analysis
Understand what purity percentages, analytical methods and certificates can tell you—and what they cannot prove.
Read article →